Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses

eLife

Volumn 3, Issue August2014, 2014, Pages 1-20

  Chiba, Shiho ^a   Ikushima, Hiroaki ^a,b   Ueki, Hiroshi ^a   Yanai, Hideyuki ^a,b,c   Kimura, Yoshitaka ^a   Hangai, Sho ^a   Nishio, Junko ^a,c   Negishi, Hideo ^a,c   Tamura, Tomohiko ^d   Saijo, Shinobu ^e   Iwakura, Yoichiro ^f   Taniguchi, Tadatsugu ^a,b,c  

^a INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; DECTIN 1; GLYCAN; INTERFERON REGULATORY FACTOR 5; PATTERN RECOGNITION RECEPTOR; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, MOUSE; LECTIN; MESSENGER RNA; POLYSACCHARIDE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SIGNALING ASSAY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENE INDUCTION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LUNG METASTASIS; MACROPHAGE; MELANOMA B16; MICROARRAY ANALYSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL COMMUNICATION; CELL PROLIFERATION; CHEMISTRY; CYTOTOXICITY; DEFICIENCY; EXPERIMENTAL MELANOMA; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS;

ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; POLYSACCHARIDES; PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 85006257599     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.04177     Document Type: Article

References (56)

1. Alderson KL, Sondel PM. 2011. Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity. Journal of Biomedicine and Biotechnology 2011:379123. doi: 10.1155/2011/379123.
2. Backer R, van Leeuwen F, Kraal G, den Haan JM. 2008. CD8-dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens. European Journal of Immunology 38:370-380. doi: 10.1002/eji.200737647.
3. Bianchi ME. 2007. DAMPs, PAMPs and alarmins: all we need to know about danger. Journal of Leukocyte Biology 81:1-5. doi: 10.1189/jlb.0306164.
4. Blasius AL, Beutler B. 2010. Intracellular toll-like receptors. Immunity 32:305-315. doi: 10.1016/j.immuni.2010.03.012.
5. Brown GD. 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nature Reviews Immunology 6:33-43. doi: 10.1038/nri1745.
6. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S. 2002. Dectin-1 is a major β-glucan receptor on macrophages. The Journal of Experimental Medicine 196:407-412. doi: 10.1084/jem.20020470.
7. Brune W, Hengel H, Koszinowski UH. 2001. A mouse model for cytomegalovirus infection. Current Protocols in Immunology Chapter 19:Unit 19 7. doi: 10.1002/0471142735.im1907s43.
8. Brunner KT, Mauel J, Cerottini JC, Chapuis B. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181-196.
9. Degli-Esposti MA, Smyth MJ. 2005. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nature Reviews Immunology 5:112-124. doi: 10.1038/nri1549.
10. del Fresno C, Soulat D, Roth S, Blazek K, Udalova I, Sancho D, Ruland J, Ardavin C. 2013. Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38:1176-1186. doi: 10.1016/j.immuni.2013.05.010.
11. Ebihara T, Azuma M, Oshiumi H, Kasamatsu J, Iwabuchi K, Matsumoto K, Saito H, Taniguchi T, Matsumoto M, Seya T. 2010. Identification of a polyI: C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. The Journal of Experimental Medicine 207:2675-2687. doi: 10.1084/jem.20091573.
12. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. 1991. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Research 51:718-723.
13. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Medicine 5:405-411. doi: 10.1038/7403.
14. Furukawa J, Shinohara Y, Kuramoto H, Miura Y, Shimaokat H, Kurogochi M, Nakano M, Nishimura SI. 2008. Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion. Analytical Chemistry 80:1094-1101. doi: 10.1021/ac702124d.
15. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nature Medicine 6:306-312. doi: 10.1038/73163.
16. Gu J, Taniguchi N. 2008. Potential of N-glycan in cell adhesion and migration as either a positive or negative regulator. Cell Adhesion & Migration 2:243-245. doi: 10.4161/cam.2.4.6748.
17. Herre J, Gordon S, Brown GD. 2004. Dectin-1 and its role in the recognition of β-glucans by macrophages. Molecular Immunology 40:869-876. doi: 10.1016/j.molimm.2003.10.007.
18. Hino S, Kito A, Yokoshima R, Sugino R, Oshima K, Morita T, Okajima T, Nadano D, Uchida K, Matsuda T. 2012. Discharge of solubilized and Dectin-1-reactive β-glucan from macrophage cells phagocytizing insoluble β-glucan particles: involvement of reactive oxygen species (ROS)-driven degradation. Biochemical and Biophysical Research Communications 421:329-334. doi: 10.1016/j.bbrc.2012.04.009.
19. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nature Reviews Immunology 6:644-658. doi: 10.1038/nri1900.
20. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T. 2004. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proceedings of the National Academy of Sciences of USA 101:15416-15421. doi: 10.1073/pnas.0406933101.
21. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. doi: 10.1038/nature03464.
22. Ikushima H, Komuro A, Isogaya K, Shinozaki M, Hellman U, Miyazawa K, Miyazono K. 2008. An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signalling. The EMBO Journal 27:2955-2965. doi: 10.1038/emboj.2008.218.
23. Ikushima H, Negishi H, Taniguchi T. 2013. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harbor Symposia on Quantitative Biology 78:105-116. doi: 10.1101/sqb.2013.78.020321.
24. Janeway CA Jnr, Medzhitov R. 2002. Innate immune recognition. Annual Review of Immunology 20:197-216. doi: 10.1146/annurev.immunol.20.083001.084359.
25. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, Vuthoori S, Ko K, Zavala F, Pamer EG, Littman DR, Lang RA. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17:211-220. doi: 10.1016/S1074-7613(02)00365-5.
26. Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, Bishop K, Honda K, Kubo M, Taniguchi T. 2008. The contribution of transcription factor IRF1 to the interferon-γ-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nature Immunology 9:34-41. doi: 10.1038/ni1538.
27. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology 11:373-384. doi: 10.1038/ni.1863.
28. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650. doi: 10.1016/j.immuni.2011.05.006.
29. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M. 2009. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457:102-106. doi: 10.1038/nature07623.
30. Leibundgut-Landmann S, Osorio F, Brown GD, Reis e Sousa C. 2008. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 112:4971-4980. doi: 10.1182/blood-2008-05-158469.
31. Meacham CE, Morrison SJ. 2013. Tumour heterogeneity and cancer cell plasticity. Nature 501:328-337. doi: 10.1038/nature12624.
32. Medzhitov R, Janeway CA Jnr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298-300. doi: 10.1126/science.1068883.
33. Morimoto-Tomita M, Ohashi Y, Matsubara A, Tsuiji M, Irimura T. 2005. Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth. Clinical & Experimental Metastasis 22:513-521. doi: 10.1007/s10585-005-3585-0.
34. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T. 2005. 22-Oxa-1α,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 26:1044-1054. doi: 10.1093/carcin/bgi049.
35. Negishi H, Matsuki K, Endo N, Sarashina H, Miki S, Matsuda A, Fukazawa K, Taguchi-Atarashi N, Ikushima H, Yanai H, Nishio J, Honda K, Fujioka Y, Ohba Y, Noda T, Taniguchi S, Nishida E, Zhang Y, Chi H, Flavell RA, Taniguchi T. 2013. Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis. Proceedings of the National Academy of Sciences of USA 110:19884-19889. doi: 10.1073/pnas.1320145110.
36. Negishi H, Yanai H, Nakajima A, Koshiba R, Atarashi K, Matsuda A, Matsuki K, Miki S, Doi T, Aderem A, Nishio J, Smale ST, Honda K, Taniguchi T. 2012. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nature Immunology 13: 659-666. doi: 10.1038/ni.2307.
37. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. 2005. FcγRIV: a novel FcR with distinct IgG subclass specificity. Immunity 23:41-51. doi: 10.1016/j.immuni.2005.05.010.
38. Nimmerjahn F, Ravetch JV. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310:1510-1512. doi: 10.1126/science.1118948.
39. Nimmerjahn F, Lux A, Albert H, Woigk M, Lehmann C, Dudziak D, Smith P, Ravetch JV. 2010. FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proceedings of the National Academy of Sciences of USA 107:19396-19401. doi: 10.1073/pnas.1014515107.
40. Pradere JP, Dapito DH, Schwabe RF. 2014. The Yin and Yang of Toll-like receptors in cancer. Oncogene 33:3485-3495. doi: 10.1038/onc.2013.302.
41. Rakoff-Nahoum S, Medzhitov R. 2009. Toll-like receptors and cancer. Nature Reviews Cancer 9:57-63. doi: 10.1038/nrc2541.
42. Rubartelli A, Lotze MT. 2007. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology 28:429-436. doi: 10.1016/j.it.2007.08.004.
43. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, Kinjo T, Nakamura K, Kawakami K, Iwakura Y. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nature Immunology 8:39-46. doi: 10.1038/ni1425.
44. Saijo S, Iwakura Y. 2011. Dectin-1 and Dectin-2 in innate immunity against fungi. International Immunology 23:467-472. doi: 10.1093/intimm/dxr046.
45. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, Yagita H, Okumura K, Tanaka N, Taniguchi T, Ogasawara K. 2001. Antiviral response by natural killer cells through TRAIL gene induction by IFN-α/β. European Journal of Immunology 31:3138-3146. doi: 10.1002/1521-4141(200111)31:113.0.CO;2-B.
46. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13:539-548. doi: 10.1016/S1074-7613(00)00053-4.
47. Seidel UJ, Schlegel P, Lang P. 2013. Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies. Frontiers in Immunology 4:76. doi: 10.3389/fimmu.2013.00076.
48. Simpson TR, Li F, Montalvo-Ortiz W, Sepulveda MA, Bergerhoff K, Arce F, Roddie C, Henry JY, Yagita H, Wolchok JD, Peggs KS, Ravetch JV, Allison JP, Quezada SA. 2013. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. The Journal of Experimental Medicine 210:1695-1710. doi: 10.1084/jem.20130579.
49. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nature Reviews Cancer 2:850-861. doi: 10.1038/nrc928.
50. Sojka DK, Plougastel-Douglas B, Yang L, Pak-Wittel MA, Artyomov MN, Ivanova Y, Zhong C, Chase JM, Rothman PB, Yu J, Riley JK, Zhu J, Tian Z, Yokoyama WM. 2014. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. eLife 3:e01659. doi: 10.7554/eLife.01659.
51. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249. doi: 10.1038/nature03308.
52. Takeda K, Nakayama M, Sakaki M, Hayakawa Y, Imawari M, Ogasawara K, Okumura K, Smyth MJ. 2011. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice. Journal of Leukocyte Biology 90:777-785. doi: 10.1189/jlb.0411208.
53. Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annual Review of Immunology 26:535-584. doi: 10.1146/annurev.immunol.26.021607.090400.
54. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, Savitsky D, Ronfani L, Akira S, Bianchi ME, Honda K, Tamura T, Kodama T, Taniguchi T. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462:99-103. doi: 10.1038/nature08512.
55. Yanai H, Chiba S, Ban T, Nakaima Y, Onoe T, Honda K, Ohdan H, Taniguchi T. 2011. Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs). Proceedings of the National Academy of Sciences of USA 108:11542-11547. doi: 10.1073/pnas.1108535108.
56. Yokoyama WM, Plougastel BF. 2003. Immune functions encoded by the natural killer gene complex. Nature Reviews Immunology 3:304-316. doi: 10.1038/nri1055.